Healthcare ETFs
IBB — iShares Biotechnology ETF
iShares · NYSE Biotechnology Index · since 2001
Large-cap biotech. Higher volatility, no pharma or device diversification.
- Expense ratio
- 0.45%
- AUM
- $6.8B
- Dividend yield
- 0.2%
- 1Y return
- +14.6%
- 3Y ann.
- +4.1%
- 5Y ann.
- +2.4%
- 10Y ann.
- —
- Since inception
- —
Top holdings
- Gilead Sciences8.40%
- Amgen8.10%
- Vertex Pharma7.60%
- Regeneron5.20%
- Alnylam4.40%
210 total holdings · 48.0% in the top 10